• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Absence of clinical disease and contact transmission of North American clade 2.3.4.4 H5NX HPAI in experimentally infected pigs

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses. 2017 Jul 8. doi: 10.1111/irv.12463. [Epub ahead of print]
[h=1]Absence of clinical disease and contact transmission of North American clade 2.3.4.4 H5NX HPAI in experimentally infected pigs.[/h] Kaplan BS[SUP]1[/SUP], Torchetti MK[SUP]2[/SUP], Lager KM[SUP]1[/SUP], Webby RJ[SUP]3[/SUP], Vincent AL[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] In the fall of 2014, clade 2.3.4.4 highly pathogenic avian influenza (HPAI) subtype H5N8 was introduced into North America by migrating waterfowl from Asia where, through reassortment, novel HPAI H5N2 and H5N1 viruses emerged.
[h=4]OBJECTIVES:[/h] Assess the susceptibility of pigs to North American HPAI clade 2.3.4.4 H5N1, H5N2, and H5N8.
[h=4]METHODS:[/h] Pigs and trachea explants were inoculated with a representative panel of clade 2.3.4.4 HPAI viruses from North America. Nasal swabs, BALF, and sera were collected to assess replication and transmission in challenged and direct contact pigs by RRT-PCR, virus isolation, hemagglutination inhibition (HI), and ELISA.
[h=4]RESULTS:[/h] Limited virus replication was restricted to the lower respiratory tract of challenged pigs, though absent in the nasal passages and trachea cultures, as determined by RRT-PCR in all samples. Seroconversion of inoculated pigs was detected by NP ELISA but was not reliably detected by antigen specific HI. Boost with adjuvanted-virus was required for the production of HI antibodies to assess cross-reactivity between wild-type avian strains. All RRT-PCR and serology tests were negative for contact animals indicating a failure of transmission from primary inoculated pigs.
[h=4]CONCLUSIONS:[/h] Clade 2.3.4.4 H5NX strains can replicate in the lower respiratory tract of swine upon high titer inoculation, though appear to be incapable of replication in swine nasal epithelium in vivo or ex vivo in trachea explants in culture. Infected pigs do not produce high levels of HI antibodies following infection. Collectively, our data show clade 2.3.4.4 HPAI H5NX viruses to be poorly adapted for replication and transmission in swine. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


PMID: 28688206 DOI: 10.1111/irv.12463
Free full text
 
Back
Top Bottom